Your browser doesn't support javascript.
loading
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
Gray, Richard; Patel, Smitaa; Ives, Natalie; Rick, Caroline; Woolley, Rebecca; Muzerengi, Sharon; Gray, Alastair; Jenkinson, Crispin; McIntosh, Emma; Wheatley, Keith; Williams, Adrian; Clarke, C E.
Afiliação
  • Gray R; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Patel S; Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
  • Ives N; Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
  • Rick C; Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
  • Woolley R; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, United Kingdom.
  • Muzerengi S; Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
  • Gray A; Department of Neurology, University Hospital, Birmingham, United Kingdom.
  • Jenkinson C; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • McIntosh E; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Wheatley K; Health Economics and Health Technology Assessment, University of Glasgow, Glasgow, United Kingdom.
  • Williams A; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences. University of Birmingham, Birmingham, UK.
  • Clarke CE; Department of Neurology, University Hospital, Birmingham, United Kingdom.
JAMA Neurol ; 79(2): 131-140, 2022 02 01.
Article em En | MEDLINE | ID: mdl-34962574

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Parkinson / Levodopa / Quimioterapia Adjuvante / Agonistas de Dopamina / Inibidores Enzimáticos / Inibidores de Catecol O-Metiltransferase / Inibidores da Monoaminoxidase / Antiparkinsonianos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Parkinson / Levodopa / Quimioterapia Adjuvante / Agonistas de Dopamina / Inibidores Enzimáticos / Inibidores de Catecol O-Metiltransferase / Inibidores da Monoaminoxidase / Antiparkinsonianos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido